However, this study had preliminarily explored the feasibility of applying the ultrasensitive Simoa technology to detect serum NFL levels in the healthy population and ALS patients in China, which laid a foundation for further research. This evidence concerns the gene NEFL and amyotrophic lateral sclerosis.